The Effect Of Low-Dose Colchicine On Cause-Specific Mortality In The Lodoco2 Trial

T. S. J. Opstal,S. M. Nidorf,A. T. L. Fiolet,J. W. Eikelboom,A. Mosterd,P. L. Thompson,C. Budgeon,J. G. P. Tijssen,W. A. Bax,J. H. Cornel

ATHEROSCLEROSIS（2021）

引用 0|浏览6

暂无评分

摘要

Background and Aims: Low-dose colchicine significantly reduces non-fatal cardiovascular events in patients with chronic coronary disease, but effects on mortality are ambiguous. Deeper insight into cause-specific mortality could address safety concerns on colchicine and fatalities.

查看译文

关键词

lodoco2 trial,mortality,low-dose,cause-specific

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要